NCT04788290View on ClinicalTrials.gov

An Observational Study Assessing Effects in Patients With Combination Therapy With Raloxifene/Cholecalciferol

CompletedOBSERVATIONAL
Enrollment

3,907

Participants

Timeline

Start Date

November 6, 2017

Primary Completion Date

July 13, 2020

Study Completion Date

July 13, 2020

Conditions
Osteoporosis
Interventions
OTHER

Observational

Rabone D®, Once daily administered per the locally approved product information

Trial Locations (1)

05545

Hanmi Pharmaceutical Company Limited, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT04788290 - An Observational Study Assessing Effects in Patients With Combination Therapy With Raloxifene/Cholecalciferol | Biotech Hunter | Biotech Hunter